Sponsor Pipeline

Shanghai HEP Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07309380 Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D Hepatitis D, Chronic Not Yet Recruiting
Phase 2
NCT06505928 A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D Hepatitis D Active, Not Recruiting
Get alerts when Shanghai HEP Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free